Mutations in muscle phosphofructokinase gene

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Muscle phosphofructokinase (PFK-M) gene mutations cause a metabolic myopathy, leading to exercise intolerance and compensated hemolysis.
• PFK deficiency, also known as glycogenosis type VII or Tarui disease, is a rare autosomal recessive disorder.
• Genetic heterogeneity is established, with multiple mutation types identified across diverse ethnic groups.

Purpose of the Study:

• To investigate the genetic basis and ethnic prevalence of PFK-M deficiency.
• To explore the feasibility of molecular diagnosis for specific populations.

Main Methods:

• Identification of various mutations (splicing defects, frameshifts, missense) in the PFK-M gene.
• Analysis of genotype-phenotype correlations.
• Prevalence assessment in different ethnic groups, particularly Ashkenazi Jewish descent.

Main Results:

• No clear correlation was found between genotype and the clinical presentation of Tarui disease.
• PFK-M deficiency shows higher prevalence in individuals of Ashkenazi Jewish descent.
• Two common PFK-M mutations are identifiable in Ashkenazi patients, enabling molecular diagnosis.

Conclusions:

• Molecular diagnosis for Tarui disease is feasible, especially in the Ashkenazi Jewish population, due to shared mutations.
• An exon 5 splicing defect is the most frequent mutation (approx. 68%) among Ashkenazi alleles.
• Further research into the genetic heterogeneity and ethnic-specific prevalence of PFK-M deficiency is warranted.